Return
Discovery of AM E3: A novel α-TLSPR monoclonal antibody for the ADC treatment of CRLF2-rearranged Ph-like B-ALL
DOI:10.1158/1538-7445.AM2024-2610.png)
Abstract
En
Journal
IF:
16.6
Papers:
10.9W
Citations:
11.9W
Organization
No organization information available

